Omacor and Docetaxel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omacor (omega-3acid ethyl esters) and Docetaxel (docetaxel). Common drug interactions include febrile neutropenia among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Omacor and Docetaxel. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Omacor?

Omacor has active ingredients of omega-3acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 2,547 Omacor users. Check the latest studies of Omacor.

What is Docetaxel?

Docetaxel has active ingredients of docetaxel. eHealthMe is studying from 79,875 Docetaxel users. Check the latest studies of Docetaxel.

On Jul, 26, 2026

15 people who take Omacor and Docetaxel together, and have interactions are studied.

What are the common drug interactions of Omacor and Docetaxel, by gender? *:

female:

Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal pain
Anaphylactic reaction (serious allergic reaction)
Chest discomfort
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Dyspnoea (difficult or laboured respiration)
Hypertension (high blood pressure)

male:

Diarrhoea
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Multiple injuries
Nervous system disorder (a general class of medical conditions affecting the nervous system)
Pain
Social problem
Dysphagia (a condition in which swallowing is difficult or painful)
Hypotension (abnormally low blood pressure)
Weight decreased

What are the common drug interactions of Omacor and Docetaxel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Anaphylactic reaction (serious allergic reaction)
Chest discomfort
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Dyspnoea (difficult or laboured respiration)
Hypertension (high blood pressure)

60+:

Diarrhoea
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Weight decreased
Neutropenia (an abnormally low number of neutrophils)
Hypokalaemia (low potassium)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal pain
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Dysphagia (a condition in which swallowing is difficult or painful)

What are the existing conditions these people have? *

High Blood Pressure: 10 people, 66.67%
Gastric Cancer (stomach cancer): 7 people, 46.67%
Pain: 5 people, 33.33%
Ocular Hypertension (intraocular pressure higher than normal): 5 people, 33.33%
Nausea (feeling of having an urge to vomit): 5 people, 33.33%
Insomnia (sleeplessness): 5 people, 33.33%
Dyslipidaemia (abnormal amount of lipids): 3 people, 20.00%
Breast Cancer: 3 people, 20.00%
Tumor: 1 person, 6.67%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Omacor and Docetaxel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously